SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-17-329546
Filing Date
2017-11-01
Accepted
2017-11-01 16:45:12
Documents
4
Effectiveness Date
2017-11-01

Document Format Files

Seq Description Document Type Size
1 S-8 d485873ds8.htm S-8 45458
2 EX-5.1 d485873dex51.htm EX-5.1 4811
3 EX-23.1 d485873dex231.htm EX-23.1 1413
4 GRAPHIC g485873g66z56.jpg GRAPHIC 2402
  Complete submission text file 0001193125-17-329546.txt   56436
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-221271 | Film No.: 171169525
SIC: 2834 Pharmaceutical Preparations